SMMT Summit Therapeutics PLC ADRs

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:SUMM.

$5.18  -0.11 (-1.99%)
As of 10/15/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  03/04/2015
Outstanding shares:  97,381,774
Average volume:  209,284
Market cap:   $514,175,767
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    86627T108
ISIN:        US86627T1088
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.20
PS ratio:   0.00
Return on equity:   -61.16%
Net income %:   -11,877.56%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy